Citi analysts have upgraded Halma plc, the FTSE 100 safety and environmental technology group, to a ‘buy’ rating, arguing that the company offers an ‘asymmetric’ upside opportunity for investors looking ahead to its financial year 2027. The upgrade, from a previous ‘neutral’ stance, reflects growing confidence in Halma’s ability to deliver sustained organic growth and margin improvements across its diversified portfolio.
Shares in Halma, which have already gained roughly 12% year-to-date, edged higher in early London trading on Tuesday. The stock was last seen trading around 2,670p, outperforming a broadly flat FTSE 100 index which stood at 8,260 points. Citi’s revised price target implies further upside of around 15% from current levels, though the bank declined to specify the exact figure in its note.
Halma operates through four sectors — safety, environmental & analysis, healthcare, and industrial — and has a long track record of compounding earnings through a decentralised acquisition model. Citi’s analysts highlighted that the company’s exposure to long-term structural trends such as water quality monitoring, fire safety regulation, and medical diagnostics provides a resilient revenue base, even as broader economic uncertainty persists.
‘We see an asymmetric risk/reward at current valuations, with consensus underestimating the potential for margin expansion and organic growth acceleration into FY27,’ Citi said in a research note. The upgrade comes after Halma’s half-year results in November showed a 10% rise in adjusted pre-tax profit, supported by strong demand in its environmental and healthcare divisions.
For UK pension holders and retail investors, the upgrade underscores the appeal of defensive growth stocks within the FTSE 100. Halma’s consistent dividend growth — the company has increased its payout for over 40 consecutive years — also makes it a favoured holding among income-focused portfolios. However, analysts caution that its premium valuation leaves little room for execution missteps.
Source: Citi Research